Zobrazeno 1 - 10
of 96
pro vyhledávání: '"M.M.A. Tilanus-Linthorst"'
Autor:
Sabine Siesling, M. Lagendijk, M.M.A. Tilanus-Linthorst, MC van Maaren, L.B. Koppert, L. de Munck, Marc Schmidt, Jelle Wesseling, Ruud M. Pijnappel
Publikováno v:
Cancer Research. 79:P1-08
Background The incidence of ductal carcinoma in situ (DCIS) has drastically increased over the past decades. Since DCIS is resected after diagnosis similarly to invasive breast cancer, the natural cause and behaviour of DCIS is not well known. We aim
Autor:
R.A.E.M. Tollenaar, H.J. de Koning, M van 't Riet, D. de Roy van Zuidewijn, H. M. Zonderland, Roger H. Mann, N. Karssemeijer, S. Saadatmand, I Mares-Engelbert, Cees Verhoef, I-M Obdeijn, M.M.A. Tilanus-Linthorst, M.J. Hooning, E.J.T. Rutgers, Jan C. Oosterwijk, Eveline A.M. Heijnsdijk, M.G.E.M. Ausems, Ernest J. T. Luiten, Marc B Lobbes, Amarens Geuzinge
Publikováno v:
Cancer Research. 79:P6-13
Background: Screening guidelines for women with a family history of breast cancer without a known causative gene mutation differ per country. No randomized controlled trial has been performed to assess the optimal screening strategy for these women.
Autor:
MC van Maaren, M.M.A. Tilanus-Linthorst, Jelle Wesseling, Marjanka K. Schmidt, Ruud M. Pijnappel, M. Lagendijk, Linetta B. Koppert, L. de Munck, Sabine Siesling
Publikováno v:
European Journal of Cancer, 101, 134-142. ELSEVIER SCI LTD
European journal of cancer, 101, 134-142. Elsevier
European Journal of Cancer, 101, 134. Elsevier Limited
European Journal of Cancer, 101, 134-142. Elsevier Ltd.
European journal of cancer, 101, 134-142. Elsevier
European Journal of Cancer, 101, 134. Elsevier Limited
European Journal of Cancer, 101, 134-142. Elsevier Ltd.
Background: The incidence of ductal carcinoma in situ (DCIS) has drastically increased over the past decades. Because DCIS is resected after diagnosis similar to invasive breast cancer, the natural cause and behaviour of DCIS is not well known. We ai
Autor:
Sabine Siesling, Lja Strobbe, Philip Poortmans, MC van Maaren, M.M.A. Tilanus-Linthorst, M. Lagendijk, L.B. Koppert, S. Saadatmand
Publikováno v:
Cancer Research. 77:P1-11
This abstract was withdrawn by the authors.
Autor:
Amarens Geuzinge, S. Saadatmand, R.A.E.M. Tollenaar, H.J. de Koning, Ernest J. T. Luiten, Eveline A.M. Heijnsdijk, A.I.M. Obdeijn, Cees Verhoef, M.J. Hooning, E.J.T. Rutgers, Marc B Lobbes, C. Loo, Roger H. Mann, M van 't Riet, M.G.E.M. Ausems, M.M.A. Tilanus-Linthorst, J.G. Oosterwijk, D. de Roy van Zuidewijn, Jelle Wesseling
Publikováno v:
European Journal of Cancer. 138:S2
Autor:
Caroline Seynaeve, C.H.M. van Deurzen, M.J. Hooning, A. Jager, Marian B. E. Menke-Pluijmers, M.M.A. Tilanus-Linthorst, L.B. Koppert, Inge-Marie Obdeijn, Bam Heemskerk-Gerritsen, J.M. Collee
Publikováno v:
Annals of Oncology, 24(8), 2029-2035. Elsevier Ltd.
To prospectively assess the efficacy of bilateral risk-reducing mastectomy (BRRM) when compared with surveillance on breast cancer (BC) risk and mortality in healthy BRCA1 and BRCA2 mutation carriers.Five hundred and seventy healthy female mutation c
Autor:
M.J. Hooning, Hester F. Lingsma, R. Kaas, Jan C. Oosterwijk, M.M.A. Tilanus-Linthorst, D Thompson, G.D. Evans, Rosalind A. Eeles, Martin O. Leach, C. J. van Asperen, E.J. Steyerberg, Peggy Manders
Publikováno v:
Cancer Research. 72:P4-11
Background: Women from high risk breast cancer families consider preventive measures including screening. Guidelines on screening differ considerably regarding starting age. We investigated whether age at diagnosis in affected family members is predi
Autor:
M.M.A. Tilanus-Linthorst, L.B. Koppert, MC van Maaren, M. Lagendijk, S. Saadatmand, Philip Poortmans, Luc J. A. Strobbe, Sabine Siesling
Publikováno v:
European Journal of Cancer. 72:S2-S3
Autor:
J.G.M. Klijn, Marian B. E. Menke-Pluymers, Hanne Meijers-Heijboer, Curt W. Burger, C.C.M. Bartels, A.M.M. Eggermont, A.N. van Geel, M.M.A. Tilanus-Linthorst, Mieke Kriege, Caroline Seynaeve, A. vd Ouweland, C.T.M. Brekelmans
Publikováno v:
European Journal of Cancer, 43(5), 867-876. Elsevier Ltd.
European journal of cancer (Oxford, England, 43(5), 867-876. Elsevier Limited
European journal of cancer (Oxford, England, 43(5), 867-876. Elsevier Limited
Aim of the study Results on tumour characteristics and survival of hereditary breast cancer (BC), especially on BRCA2-associated BC, are inconclusive. The prognostic impact of the classical tumour and treatment factors in hereditary BC is insufficien
Autor:
Inge Marie Obdeijn, C.T.M. Brekelmans, M. Menke, E.J. Meijers-Heijboer, C. M. G. Crepin, J.G.M. Klijn, C.C.M. Bartels, L.C. Verhoog, A.N. van Geel, M.M.A. Tilanus-Linthorst, A. M. W. Van Den Ouweland, Caroline Seynaeve
Publikováno v:
Journal of clinical oncology, 19(4), 924-930. American Society of Clinical Oncology
PURPOSE: Women with a high breast cancer risk due to a familial predisposition may choose between preventive surgery and regular surveillance. The effectiveness of surveillance in high-risk women and especially BRCA1/2 mutation carriers is unknown. W